JERUSALEM, September 3, 2014 /PRNewswire/ --
Oramed Pharmaceuticals Inc. (ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the Company's CEO, Nadav Kidron will present at the following conferences in September 2014:
2014 Rodman & Renshaw Global Investment Conference
Date: Tuesday, September 9, 2014
Time: 10:00am Eastern Time
Location: New York Palace Hotel, Holmes I Salon
A webcast of the presentation can be viewed at http://wsw.com/webcast/rrshq24/ormp and will be archived for an additional 90 days.
2014 Aegis Healthcare and Technology Conference
Date: Thursday, September 11, 2014
Time: 9:00am Eastern Time
Location: The Encore at Wynn Las Vegas, Room 2
About Oramed Pharmaceuticals
Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, Oramed's Protein Oral Delivery (POD[TM]) technology is based on over 30 years of research by top scientists at Jerusalem's Hadassah Medical Center. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801). Having completed separate Phase IIa clinical trials, the company anticipates the initiation of separate Phase IIb clinical trials, in patients with both type 1 and type 2 diabetes under an Investigational New Drug application with the U.S. Food and Drug Administration. In addition the company is developing an oral GLP-1 analog capsule (ORMD-0901).
For more information, the content of which is not part of this press release, please visit http://www.oramed.com
Company Contact:
Oramed Pharmaceuticals
Ariella Nachman
Office: +972-2-566-0001 ext. 2
US: +1-718-831-2512 ext. 3
Email: ariella@oramed.com
US Investor Relations Contact:
LHA
Anne Marie Fields
Senior Vice President
US: +1-212-838-3777
Email: afields@lhai.com
Help employers find you! Check out all the jobs and post your resume.
